Advertisement
Screener

Merck & Co., Inc. (MRK) Return on Tangible Equity

2.8 / 5 stars · 68/120 Roast Me

Merck & Co., Inc. Return Tang Equity

Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • Merck & Co., Inc. return tang equity for the quarter ending 2026-06-30 was -16.65%, a change of 120.21% year-over-year.
  • Merck & Co., Inc. return tang equity for the quarter ending 2026-03-31 was -59.15%, a change of 77.70% year-over-year.
  • Merck & Co., Inc. return tang equity for the quarter ending 2025-12-31 was -218.01%, a change of -101.98% year-over-year.
  • Merck & Co., Inc. return tang equity for the quarter ending 2025-09-30 was -208.34%, a change of -135.13% year-over-year.
  • Merck & Co., Inc. return tang equity for fiscal 2025 was -218.01%, a change of -101.98% from fiscal 2024.
  • Merck & Co., Inc. return tang equity for fiscal 2024 was -116.03%, a change of -114.45% from fiscal 2023.
  • Merck & Co., Inc. return tang equity for fiscal 2023 was -1.59%, a change of 97.85% from fiscal 2022.
  • Merck & Co., Inc. return tang equity for fiscal 2022 was -99.43%, a change of -41.34% from fiscal 2021.
Available history
2007-12-31 to 2026-06-30
Data captured

Historical Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2026-06-30-16.65%$3.17B-$19.05B
2026-03-31-59.15%$8.94B-$15.11B
2025-12-31-218.01%$18.25B-$8.37B
2025-09-30-208.34%$19.03B-$9.14B
2025-06-30-136.86%$16.41B-$11.99B
2025-03-31-136.84%$17.43B-$12.74B
2024-12-31-116.03%$17.12B-$14.75B
2024-09-30-73.21%$12.15B-$16.59B
2024-06-30-80.95%$13.74B-$16.97B
2024-03-31-11.41%$2.31B-$20.21B
2023-12-31-1.59%$365M-$23.02B
2023-09-30-23.83%$4.61B-$19.34B
2023-06-30-14.20%$3.11B-$21.91B
2023-03-31-94.69%$13.03B-$13.76B
2022-12-31-99.43%$14.52B-$14.6B
2022-09-30-94.83%$15.26B-$16.09B
2022-06-30-95.55%$16.58B-$17.35B
2022-03-31-71.76%$14.18B-$19.76B
2021-12-31-58.09%$13.05B-$22.46B
2021-09-30-32.05%$7.2B-$22.46B
2021-06-30-22.34%$5.57B-$24.94B
2021-03-31-21.54%$7.03B-$32.63B
2020-12-31-21.46%$7.07B-$32.93B
2020-09-30-37.85%$11.52B-$30.43B
2020-06-30-32.97%$10.48B-$31.78B
2020-03-31-30.82%$10.15B-$32.92B
2019-12-31-31.22%$9.84B-$31.52B
2019-09-30-29.09%$9.31B-$32.01B
2019-06-30-30.00%$9.36B-$31.21B
2019-03-31-28.04%$8.4B-$29.96B
2018-12-31-20.18%$6.22B-$30.83B
2018-09-30-13.36%$3.35B-$25.06B
2018-06-30-5.37%$1.34B-$24.96B
2018-03-31-6.62%$1.58B-$23.86B
2017-12-31-10.34%$2.4B-$23.17B
2017-09-30-14.75%$2.85B-$19.3B
2017-06-30-28.10%$5.09B-$18.1B
2017-03-31-24.51%$4.35B-$17.73B
2016-12-31-22.64%$3.92B-$17.31B
2016-09-30-39.91%$5.49B-$13.76B
2016-06-30-37.14%$5.13B-$13.82B
2016-03-31-34.60%$4.62B-$13.34B
2015-12-31-35.80%$4.44B-$12.41B
2015-09-30-93.45%$10.78B-$11.54B
2015-06-30-93.60%$9.85B-$10.53B
2015-03-31-120.36%$11.17B-$9.28B
2014-12-31-325.95%$11.92B-$3.66B
2014-09-30-74.10%$5.39B-$7.27B
2014-06-30-205.72%$5.61B-$2.73B
2014-03-31457.09%$4.52B$988M
2013-12-31773.99%$4.4B$569M
2013-09-30-288.35%$4.53B-$1.57B
2013-06-30-331.50%$5.14B-$1.55B
2013-03-31152.73%$6.02B$3.94B
2012-12-31159.23%$6.17B$3.87B
2012-09-30102.79%$6.77B$6.59B
2012-06-30111.16%$6.74B$6.06B
2012-03-31122.17%$6.97B$5.7B
2011-12-31117.61%$6.27B$5.33B
2011-09-3071.50%$4.23B$5.91B
2011-06-3047.29%$2.88B$6.08B
2011-03-3131.01%$1.61B$5.18B
2010-12-3117.32%$861M$4.97B
2010-09-30-360.14%$7.89B-$2.19B
2010-06-30-471.67%$10.97B-$2.33B
2010-03-313775.82%$11.77B$311.8M
2009-12-31763.25%$12.9B$1.69B
2009-09-3077.78%$12.82B$16.49B
2009-06-3071.59%$10.01B$13.99B

Annual Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2025-12-31-218.01%$18.25B-$8.37B
2024-12-31-116.03%$17.12B-$14.75B
2023-12-31-1.59%$365M-$23.02B
2022-12-31-99.43%$14.52B-$14.6B
2021-12-31-58.09%$13.05B-$22.46B
2020-12-31-21.46%$7.07B-$32.93B
2019-12-31-31.22%$9.84B-$31.52B
2018-12-31-20.18%$6.22B-$30.83B
2017-12-31-10.33%$2.39B-$23.17B
2016-12-31-22.65%$3.92B-$17.31B
2015-12-31-35.79%$4.44B-$12.41B
2014-12-31-325.95%$11.92B-$3.66B
2013-12-31773.99%$4.4B$569M
2012-12-31159.26%$6.17B$3.87B
2011-12-31117.63%$6.27B$5.33B
2010-12-3117.32%$861M$4.97B
2009-12-31763.25%$12.9B$1.69B
2008-12-3139.58%$7.81B$19.73B
2007-12-3115.91%$3.28B$20.59B

Similar stocks

Stock NameCountryMarket CapPE Ratio
AbbVie Inc. (ABBV)United States$468.180B70.37
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
PFIZER INC (PFE)United States$162.042B31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
JOHNSON & JOHNSON (JNJ)United States$652.528B29.10
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60